Honz Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Honz Pharmaceutical Co Ltd with three other
companies in this sector in China:
Lanzhou Foci Pharmaceutical Co Limited
sales of 501.14 million Chinese Renmimbi [US$72.40 million]
of which 100%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
(497.69 million Chinese Renmimbi [US$71.90 million]
Guangdong Jiaying Pharmaceutical Co., Limited
(468.08 million Chinese Renmimbi [US$67.62 million]
of which 99%
was Pharmaceuticals Industry).
During the year ended December of 2017, sales at
Honz Pharmaceutical Co Ltd were 480.81 million Chinese Renmimbi (US$69.46 million).
a very small
increase of 2.0%
versus 2016, when the company's sales were 471.46 million Chinese Renmimbi.
This was the fourth straight year of sales growth at Honz Pharmaceutical Co Ltd.